<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3993628&amp;fmt=gif">
Skip to the main content.

Stroke and Ischemia Models

SPEAK WITH A SCIENTIST

mdbiosciences-neurology-leading-preclinical-CRO-1

Advancing Preclinical Research with Stroke and Ischemia Models

MD Biosciences provides well-characterized stroke models, including rodent models for focal ischemia (permanent and transient MCAo) and global ischemia (4VO). These models closely replicate human stroke, offering essential insights into injury mechanisms, cell damage, and drug efficacy in targeting neurodegeneration and neuroinflammation.

Speak with a scientist
 
Scientific Data

Diversity in Stroke Models

The figure shows grip test results in the MCAo stroke model, revealing significant differences between young and aged males, as well as between aged males and aged females.

Assessments

MD Biosciences offers comprehensive in vivo measures and endpoint assessments, delivering robust data packages to support critical research decisions in the evolving landscape of drug development and biomedical research.

behavior

Behavior 

Conduct extensive pain, sensory, motor, and cognitive behavioral testing.

biomarker

Biomarkers

Explore inflammatory and pain biomarkers in disease-specific tissues.

histology

Histology

Characterize tissue and cellular changes in disease, pain, and neurodegeneration.

READY TO DISCUSS YOUR PROGRAM?

MD Biosciences is your dedicated partner in drug development, offering tailored study designs, translational models, and comprehensive endpoints. With short lead times, competitive pricing, and deep scientific expertise, we help move your pipeline forward efficiently.

Request Proposal